Cocaine production in South America is surging, and much of that is being found and seized at the U.S.-Mexico border.

As part of a new $55 billion investment nationally, pharmaceutical giant Johnson & Johnson is investing in a manufacturing facility in North Carolina.

Cocaine again is making headlines 40 years after Pablo Escobar and his Medellin cartel flooded America with “blow.” ...

Following big announcements from Lilly and Merck, J&J is pledging $55 billion over the next four years to open new plants.

Heart disease patients now have another treatment option. The U.S. Food and Drug Administration has approved Alnylam ...

Alnylam Pharmaceuticals' shares rose about 7% before the bell on Friday following U.S. approval for its drug for a rare and deadly heart disease, securing an entry into a market dominated by Pfizer's ...

A patient with a rare illness would have died if it weren't for AI-powered drug repurposing: When side effects come to the ...

Johnson & Johnson has laid out plans to raise U.S. investments by 25% to more than $55 billion over the next four years, as a ...

Jiangsu Hengrui Pharmaceuticals and its partner Elevar Therapeutics will have to wait even longer before their PD-1 inhibitor ...

On March 19, the U.S. Food and Drug Administration (FDA) issued a Class II recall notice on Great Lakes Cheese Co. Inc., the ...

Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. Mounjaro and ...

Over 60% of prescriptions for conditions like hypertension and mental health disorders in the US rely on Indian-made drugs, ...